Crispr Therapeutics

Crispr Therapeutics, based in Medford, MA, is at the forefront of gene editing innovation, dedicated to transforming the lives of patients with serious diseases. With a diverse portfolio that includes therapies for hemoglobinopathies, oncology, autoimmune diseases, and regenerative medicine, the company is committed to rapidly translating revolutionary technology into effective treatments.

Their notable achievements include the first-ever approved CRISPR-based therapy, demonstrating a powerful collaboration with Vertex Pharmaceuticals. Recognized for excellence in the biopharmaceutical industry, Crispr Therapeutics continues to push the boundaries of science and develop gene-based medicines that have the potential to significantly impact patient health.

Generated from the website